| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Raffaella Willmann, Stefanie Possekel, Judith Dubach-Powell, Thomas Meier, Markus A Rueg. Mammalian animal models for Duchenne muscular dystrophy. Neuromuscular disorders : NMD. vol 19. issue 4. 2009-07-28. PMID:19217290. |
in the frame of "treat-nmd", a european network of excellence addressing the fragmentation in the assessment and treatment of neuromuscular diseases, we compare here the currently used mammalian animal models for dmd with the aim of selecting and recommending the most appropriate ones for preclinical efficacy testing of new therapeutic strategies. |
2009-07-28 |
2023-08-12 |
Not clear |
| Jachinta E Rooney, Praveen B Gurpur, Dean J Burki. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. vol 106. issue 19. 2009-06-22. PMID:19416897. |
duchenne muscular dystrophy (dmd) is a devastating neuromuscular disease caused by mutations in the gene encoding dystrophin. |
2009-06-22 |
2023-08-12 |
mouse |
| Bryan C Werner, Andrew J Skalsky, Craig M McDonald, Jay J Ha. Convexity of scoliosis related to handedness in identical twin boys with Duchenne's muscular dystrophy: a case report. Archives of physical medicine and rehabilitation. vol 89. issue 10. 2008-11-18. PMID:18929032. |
the unique clinical presentation of progressive neuromuscular disease and scoliosis in monozygotic twins should allow for a unique evaluation of some of the contributory factors associated with the development of neuromuscular scoliosis in dmd. |
2008-11-18 |
2023-08-12 |
Not clear |
| M Schoeffler, F Wallet, M O Robert, G Tramoni, S Workineh, J P Viale, S Duperre. [Increased troponin I level in a Duchenne muscular dystrophy patient with normal coronarography]. Annales francaises d'anesthesie et de reanimation. vol 27. issue 4. 2008-09-15. PMID:18468552. |
duchenne muscular dystrophy (dmd) is a neuromuscular disease characterized by a progressive skeletal muscular weakness. |
2008-09-15 |
2023-08-12 |
Not clear |
| Lu-Lu Xiao, Wei Chen, Cheng Zhang, Zhuo-Lin Liu, Xin Ye, Wei-Dong Zhang, Yan Y. [A probability analysis for HLA matching in adult stem cell transplantation treating nervous genetic diseases]. Zhongguo shi yan xue ye xue za zhi. vol 12. issue 6. 2008-08-25. PMID:15631675. |
it is concluded that stem cells transplantation therapy for dmd patients is feasible, which will benefit these patients suffered from the lethal neuromuscular disease, and create a new way to treat this tough nervous system disease. |
2008-08-25 |
2023-08-12 |
Not clear |
| S S Bhat, K R Schmidt, S Ladd, K C Kim, C E Schwartz, R J Simensen, B R DuPont, R E Stevenson, A K Srivastav. Disruption of DMD and deletion of ACSL4 causing developmental delay, hypotonia, and multiple congenital anomalies. Cytogenetic and genome research. vol 112. issue 1-2. 2006-02-03. PMID:16276108. |
these findings suggest that the disruption of dmd and the absence of acsl4 in the patient are responsible for neuromuscular disease and cognitive impairment. |
2006-02-03 |
2023-08-12 |
Not clear |
| Sadasivam Suresh, Patricia Wales, Carolyn Dakin, Margaret-Anne Harris, David Gus M Coope. Sleep-related breathing disorder in Duchenne muscular dystrophy: disease spectrum in the paediatric population. Journal of paediatrics and child health. vol 41. issue 9-10. 2006-01-26. PMID:16150067. |
duchenne muscular dystrophy (dmd) is a progressive neuromuscular disease with death usually occurring because of respiratory failure. |
2006-01-26 |
2023-08-12 |
Not clear |
| Simona Zanotti, Tiziana Negri, Cristina Cappelletti, Pia Bernasconi, Eleonora Canioni, Claudia Di Blasi, Elena Pegoraro, Corrado Angelini, Patrizia Ciscato, Alessandro Prelle, Renato Mantegazza, Lucia Morandi, Marina Mor. Decorin and biglycan expression is differentially altered in several muscular dystrophies. Brain : a journal of neurology. vol 128. issue Pt 11. 2005-11-28. PMID:16183658. |
we examined muscle biopsies from nine dmd patients, aged 2-8 years; 14 bmd (becker muscular dystrophy) patients (nine aged 1-5 years; five aged 30-37 years); four mdc1a patients (aged 2-7 years); six dysferlin-deficient patients (aged 19-53 years) with mutation ascertained in two, and normal expression of proteins related to limb girdle muscular dystrophies in the others; 10 sarcoglycan-deficient patients: seven with alpha-sarcoglycan mutation, two with beta-sarcoglycan mutation and one with gamma-sarcoglycan mutation (five aged 8-15 years; five aged 26-43 years); and nine children (aged 1-6 years) and 12 adults (aged 16-61 years) suspected of neuromuscular disease, but who had normal muscle on biopsy. |
2005-11-28 |
2023-08-12 |
Not clear |
| David Touboul, Hélène Piednoël, Vincent Voisin, Sabine De La Porte, Alain Brunelle, Frédéric Halgand, Olivier Laprévot. Changes of phospholipid composition within the dystrophic muscle by matrix-assisted laser desorption/ionization mass spectrometry and mass spectrometry imaging. European journal of mass spectrometry (Chichester, England). vol 10. issue 5. 2005-01-04. PMID:15531799. |
duchenne muscular dystrophy (dmd) is a neuromuscular disease linked to the lack of the dystrophin, a submembrane protein, leading to muscle weakness and associated with a defect of the lipid metabolism. |
2005-01-04 |
2023-08-12 |
mouse |
| Thomas O B Krag, Sasha Bogdanovich, Claus J Jensen, M Dominik Fischer, Jacob Hansen-Schwartz, Elisabeth H Javazon, Alan W Flake, Lars Edvinsson, Tejvir S Khuran. Heregulin ameliorates the dystrophic phenotype in mdx mice. Proceedings of the National Academy of Sciences of the United States of America. vol 101. issue 38. 2004-12-03. PMID:15365169. |
duchenne's muscular dystrophy (dmd) is a fatal neuromuscular disease caused by absence of dystrophin. |
2004-12-03 |
2023-08-12 |
mouse |
| Florencia Giliberto, Verónica Ferreiro, Viviana Dalamón, Ezequiel Surace, Javier Cotignola, Sebastián Esperante, Daniel Borelina, Sergio Baranzini, Irene Szija. Direct deletion analysis in two Duchenne muscular dystrophy symptomatic females using polymorphic dinucleotide (CA)n loci within the dystrophin gene. Journal of biochemistry and molecular biology. vol 36. issue 2. 2004-01-12. PMID:12689516. |
duchenne muscular dystrophy (dmd) is the most common hereditary neuromuscular disease. |
2004-01-12 |
2023-08-12 |
human |
| Isabelle Courdier-Fruh, Lee Barman, Philipp Wettstein, Thomas Meie. Detection of glucocorticoid-like activity in traditional Chinese medicine used for the treatment of Duchenne muscular dystrophy. Neuromuscular disorders : NMD. vol 13. issue 9. 2003-12-16. PMID:14561491. |
anecdotal reports of positive influence of certain traditional chinese medicines on the progression of neuromuscular diseases in general and duchenne muscular dystrophy (dmd) in particular has raised interest in patient support groups and clinical experts alike. |
2003-12-16 |
2023-08-12 |
human |
| S Pradha. Valley sign in duchenne muscular dystrophy: importance in patients with inconspicuous calves. Neurology India. vol 50. issue 2. 2002-08-14. PMID:12134184. |
the new sign was examined by 3 independent observers in these 12 dmd patients and in 10 patients with other neuromuscular diseases. |
2002-08-14 |
2023-08-12 |
Not clear |
| Mads Gyrd-Hansen, Thomas O B Krag, Alan G Rosmarin, Tejvir S Khuran. Sp1 and the ets-related transcription factor complex GABP alpha/beta functionally cooperate to activate the utrophin promoter. Journal of the neurological sciences. vol 197. issue 1-2. 2002-07-03. PMID:11997063. |
duchenne muscular dystrophy (dmd) is a fatal neuromuscular disease caused by the absence of dystrophin. |
2002-07-03 |
2023-08-12 |
drosophila_melanogaster |
| K Gieseler, K Grisoni, L Ségala. Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans. Current biology : CB. vol 10. issue 18. 2000-12-07. PMID:10996789. |
dystrophin is the product of the gene that is mutated in duchenne muscular dystrophy (dmd), a progressive neuromuscular disease for which no treatment is available. |
2000-12-07 |
2023-08-12 |
mouse |
| A H Ligon, C D Kashork, C S Richards, L G Shaffe. Identification of female carriers for Duchenne and Becker muscular dystrophies using a FISH-based approach. European journal of human genetics : EJHG. vol 8. issue 4. 2000-09-01. PMID:10854113. |
duchenne muscular dystrophy (dmd) and becker muscular dystrophy (bmd) are x-linked recessive neuromuscular diseases caused by dystrophin gene mutations. |
2000-09-01 |
2023-08-12 |
Not clear |
| M A Alcántara, M T Villarreal, V Del Castillo, G Gutiérrez, Y Saldaña, I Maulen, R Lee, M Macías, L Orozc. High frequency of de novo deletions in Mexican Duchenne and Becker muscular dystrophy patients. Implications for genetic counseling. Clinical genetics. vol 55. issue 5. 1999-08-24. PMID:10422811. |
duchenne muscular dystrophy (dmd) is the most common lethal hereditary neuromuscular disease. |
1999-08-24 |
2023-08-12 |
Not clear |
| Y Saito, T Komiya, M Kawa. [Hypercoagulable state in Duchenne muscular dystrophy]. Rinsho shinkeigaku = Clinical neurology. vol 37. issue 5. 1997-12-16. PMID:9294322. |
significantly smaller number of the control patients suffering from other neuromuscular diseases showed abnormal results, while the ambulatory dmd patients not infrequently showed hypercoagulable state. |
1997-12-16 |
2023-08-12 |
Not clear |
| A Marbini, F Gemignani, M F Bellanova, D Guidetti, A Ferrar. Immunohistochemical localization of utrophin and other cytoskeletal proteins in skin smooth muscle in neuromuscular diseases. Journal of the neurological sciences. vol 143. issue 1-2. 1997-03-20. PMID:8981315. |
we investigated the immunohistochemical distribution of cytoskeletal proteins in smooth muscles of 15 patients with duchenne muscular dystrophy (dmd), 8 patients with becker muscular dystrophy (bmd), 28 patients with various neuromuscular diseases, and 2 normal controls, performing skin and muscle biopsies. |
1997-03-20 |
2023-08-12 |
Not clear |
| A Marbini, F Gemignani, M F Bellanova, D Guidetti, A Ferrar. Immunohistochemical localization of utrophin and other cytoskeletal proteins in skin smooth muscle in neuromuscular diseases. Journal of the neurological sciences. vol 143. issue 1-2. 1997-03-20. PMID:8981315. |
dystrophin immunostaining confirmed absent reaction in the arrector pili muscles of dmd patients, faint positive reaction in bmd patients, and strong dystrophin reaction in patients with other neuromuscular diseases and normal controls. |
1997-03-20 |
2023-08-12 |
Not clear |